Factors of Importance for Scintigraphic Non-visualisation of Sentinel Nodes in Breast Cancer

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2005 Mar 26

PMID 15791437

Citations 11

Authors

A H Chakera

E Friis

U Hesse

N Al-Suliman

B Zerahn

B Hesse

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this study was to analyse different factors of possible significance for non-visualisation of sentinel nodes (SNs) by preoperative lymphoscintigraphy, in order to enable improvement of the success rate of SN visualisation through modification or alteration of some of the factors.

Methods: Between March 1998 and January 2003 we analysed a series of 442 women with unilateral stage T1 and clinical N0 breast cancer. Lymphoscintigraphy was performed after periareolar or peritumoural injection of 99mTc-albumin nanocolloid, with image acquisition after 2-6 h or 18-24 h. Until January 2001, all patients received around 20 MBq tracer, irrespective of time to operation. From January 2001, patients injected on the day before surgery received at least 100 MBq while patients injected on the day of surgery received around 50 MBq.

Results: An SN was visualised in 87% of the patients, and at surgery the SN was detected with the hand-held gamma probe in 42% of the remaining patients. By multiple logistic regression analysis, statistically significant independent variables that increased the risk for non-visualisation were increasing age (p=0.0007), increasing body weight (p=0.0189) and peritumoural injection (p<0.0001). Significant interaction was found for imaging time and injected activity (p=0.0017).

Conclusion: This study conclusively shows that the risk of unsuccessful SN imaging increases with age and body weight. Our findings suggest that the scintigraphic success rate may be improved by periareolar (rather than peritumoural) injection. Early and late imaging procedures are equally efficient, but if a late imaging procedure is used, activity (adjusted for physical decay) in the patient on day 2 should be more than 10 MBq.

Citing Articles

Risk factors for nonvisualization of the sentinel lymph node on lymphoscintigraphy in breast cancer patients.

Chahid Y, Qiu X, van de Garde E, Verberne H, Booij J EJNMMI Res. 2021; 11(1):54.

PMID: 34106341 PMC: 8190239. DOI: 10.1186/s13550-021-00793-8.

Prognostic Role of Non-Identification of Sentinel Lymph Node in Cutaneous Melanoma Patients: An Observational Retrospective Study.

Moro R, Arjona-Aguilera C, Requena C, Pont-Sanjuan V, Traves V, Manrique-Silva E Cancers (Basel). 2020; 12(11).

PMID: 33121093 PMC: 7692392. DOI: 10.3390/cancers12113151.

Biological Subtypes of Breast Cancer and Sentinel Lymph Node Biopsy.

Colakoglu M, Guven E, Akgul G, Dogan L, Gulcelik M Eur J Breast Health. 2018; 14(2):100-104.

PMID: 29774318 PMC: 5939972. DOI: 10.5152/ejbh.2018.3780.

Sentinel Lymph Node Detection in Contralateral Axilla at Initial Presentation of a Breast Cancer Patient: Case Report.

Vural G, Sahiner I, Demirtas S, Efeturk H, Demirel B Mol Imaging Radionucl Ther. 2015; 24(2):90-3.

PMID: 26316476 PMC: 4563177. DOI: 10.4274/mirt.91300.

(99m)Tc-Phytate Lymphoscintigraphy for Detection of Sentinel Node: Preliminary Results of the First Year's Clinical Experience in Isfahan, Iran.

Moslehi M, Shanei A, Hakimian S, Mahmoudi G, Baradaran-Ghahfarokhi M J Med Signals Sens. 2015; 5(1):69-74.

PMID: 25709943 PMC: 4335147.

References

Haigh P, Hansen N, Giuliano A, EDWARDS G, Ye W, Glass E . Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. J Nucl Med. 2000; 41(10):1682-8. View

Mateos J, Vidal-Sicart S, Zanon G, Pahisa J, Fuster D, Martin F . Sentinel lymph node biopsy in breast cancer patients: subdermal versus peritumoural radiocolloid injection. Nucl Med Commun. 2001; 22(1):17-24. DOI: 10.1097/00006231-200101000-00003. View

Tanis P, van Sandick J, Nieweg O, Valdes Olmos R, Rutgers E, Hoefnagel C . The hidden sentinel node in breast cancer. Eur J Nucl Med Mol Imaging. 2002; 29(3):305-11. DOI: 10.1007/s00259-001-0732-y. View

Valdes Olmos R, Tanis P, Hoefnagel C, Nieweg O, Muller S, Rutgers E . Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun. 2001; 22(5):579-86. DOI: 10.1097/00006231-200105000-00018. View

De Cicco C, Trifiro G, Intra M, Marotta G, Ciprian A, Frasson A . Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions. Eur J Nucl Med Mol Imaging. 2003; 31(3):349-54. DOI: 10.1007/s00259-003-1390-z. View

Reitsamer R, Peintinger F, Rettenbacher L, Prokop E, Sedlmayer F . Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients. World J Surg. 2003; 27(12):1291-4. DOI: 10.1007/s00268-003-7001-0. View

Shimazu K, Tamaki Y, Taguchi T, Takamura Y, Noguchi S . Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery. 2002; 131(3):277-86. DOI: 10.1067/msy.2002.121378. View

Klimberg V, Rubio I, Henry R, Cowan C, Colvert M, Korourian S . Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg. 1999; 229(6):860-4; discussion 864-5. PMC: 1420833. DOI: 10.1097/00000658-199906000-00013. View

Cox C, Dupont E, Whitehead G, Ebert M, Nguyen K, Peltz E . Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J. 2002; 8(2):88-91. DOI: 10.1046/j.1524-4741.2002.08203.x. View

10.

Pelosi E, Bello M, Giors M, Ala A, Giani R, Bussone R . Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques. J Nucl Med. 2004; 45(2):220-5. View

11.

Borgstein P, Meijer S, Pijpers R, van Diest P . Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg. 2000; 232(1):81-9. PMC: 1421111. DOI: 10.1097/00000658-200007000-00012. View

12.

McMasters K, Wong S, Martin 2nd R, Chao C, Tuttle T, Noyes R . Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg. 2001; 233(5):676-87. PMC: 1421308. DOI: 10.1097/00000658-200105000-00012. View

13.

. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Administration of Radioactive Substances Advisory Committee. Nucl Med Commun. 2000; 21 Suppl:S1-93. View

14.

Brenot-Rossi I, Houvenaeghel G, Jacquemier J, Bardou V, Martino M, Hassan-Sebbag N . Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?. J Nucl Med. 2003; 44(8):1232-7. View

15.

Krausz Y, Ikeda D, Jadvar H, Langleben D, Birdwell R, Strauss H . Non-visualization of sentinel lymph node in patients with breast cancer. Nucl Med Commun. 2001; 22(1):25-32. DOI: 10.1097/00006231-200101000-00004. View

16.

Leppanen E, Leidenius M, Krogerus L, von Smitten K . The effect of patient and tumour characteristics on visualization of sentinel nodes after a single intratumoural injection of Tc 99m labelled human albumin colloid in breast cancer. Eur J Surg Oncol. 2002; 28(8):821-6. DOI: 10.1053/ejso.2002.1325. View

17.

Derossis A, Fey J, Cody 3rd H, Borgen P . Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer. J Am Coll Surg. 2003; 197(6):896-901. DOI: 10.1016/j.jamcollsurg.2003.08.005. View

18.

Hughes M, Goffman T, Perry R, Laronga C . Obesity and lymphatic mapping with sentinel lymph node biopsy in breast cancer. Am J Surg. 2004; 187(1):52-7. DOI: 10.1016/j.amjsurg.2003.04.004. View

19.

Birdwell R, Smith K, Betts B, Ikeda D, Strauss H, Jeffrey S . Breast cancer: variables affecting sentinel lymph node visualization at preoperative lymphoscintigraphy. Radiology. 2001; 220(1):47-53. DOI: 10.1148/radiology.220.1.r01jn2347. View

20.

Valdes-Olmos R, Jansen L, Hoefnagel C, Nieweg O, Muller S, Rutgers E . Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification. J Nucl Med. 2000; 41(9):1500-6. View